Rhofade
- Product NDC
- 71403-003
- 11-digit product format
- 714030003
- Labeler code
- 71403
- Product ID
- 71403-003_d743c06d-1277-4504-803b-5752af09ba03
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXYMETAZOLINE HYDROCHLORIDE
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- EPI Health, LLC
- Application
- NDA208552
- Marketing category
- NDA
- Marketing start
- 2021-01-18
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- 1 g/100g
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rhofade
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXYMETAZOLINE HYDROCHLORIDE | 1 g/100g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K89MJ0S5VY |
| Rxcui | 1869816, 1869821 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71403-003-15 | 2023-05-19 | C162847 | 48780-1 | f386c649-c8fa-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 |
| 71403-003-30 | 2023-05-19 | C162847 | 48780-1 | f386c649-c8fa-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 |
| 71403-003-15 | 2023-01-30 | C162847 | 48780-1 | f386c649-c8fa-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 |
| 71403-003-30 | 2023-01-30 | C162847 | 48780-1 | f386c649-c8fa-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use RHOFADE ® topical cream safely and effectively. See full prescribing information for RHOFADE ® topical cream. RHOFADE ® (oxymetazoline hydrochloride) cream, 1%, for topical use Initial U.S. Approval: 1964 |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71403-003 | RHOFADE (OXYMETAZOLINE HYDROCHLORIDE) CREAM [EPI HEALTH, LLC] | 2 | Current NDC, Legacy NDC, 4 package rows | 20230520_e82b5788-a855-4165-a81f-7f15cb874612.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71403-003-15 | 71403000315 | 1 TUBE in 1 CARTON (71403-003-15) / 3 g in 1 TUBE | 1 tube | 2021-01-18 | 0000-00-00 | No | No | Current |
| 71403-003-30 | 71403000330 | 1 TUBE in 1 CARTON (71403-003-30) / 30 g in 1 TUBE | 1 tube | 2021-01-18 | 0000-00-00 | No | No | Current |